• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计和评估一种针对新冠病毒后持续性嗅觉丧失患者的潜在非侵入性神经刺激治疗策略。

Design and Evaluation of a Potential Non-Invasive Neurostimulation Strategy for Treating Persistent Anosmia in Post-COVID-19 Patients.

机构信息

Brain-Machine Interface Systems Lab, Miguel Hernandez University of Elche, 03202 Elche, Spain.

Engineering Research Institute of Elche-I3E, Miguel Hernandez University of Elche, 03202 Elche, Spain.

出版信息

Sensors (Basel). 2023 Jun 25;23(13):5880. doi: 10.3390/s23135880.

DOI:10.3390/s23135880
PMID:37447728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10346661/
Abstract

A new pandemic was declared at the end of 2019 because of coronavirus disease 2019 (COVID-19). One of the effects of COVID-19 infection is anosmia (i.e., a loss of smell). Unfortunately, this olfactory dysfunction is persistent in around 5% of the world's population, and there is not an effective treatment for it yet. The aim of this paper is to describe a potential non-invasive neurostimulation strategy for treating persistent anosmia in post-COVID-19 patients. In order to design the neurostimulation strategy, 25 subjects who experienced anosmia due to COVID-19 infection underwent an olfactory assessment while their electroencephalographic (EEG) signals were recorded. These signals were used to investigate the activation of brain regions during the olfactory process and identify which regions would be suitable for neurostimulation. Afterwards, 15 subjects participated in the evaluation of the neurostimulation strategy, which was based on applying transcranial direct current stimulation (tDCS) in selected brain regions related to olfactory function. The results showed that subjects with lower scores in the olfactory assessment obtained greater improvement than the other subjects. Thus, tDCS could be a promising option for people who have not fully regained their sense of smell following COVID-19 infection.

摘要

2019 年底,由于 2019 年冠状病毒病(COVID-19)的爆发,宣布了一种新的大流行。COVID-19 感染的影响之一是嗅觉丧失(即嗅觉丧失)。不幸的是,这种嗅觉功能障碍在世界人口中约有 5%持续存在,目前还没有有效的治疗方法。本文旨在描述一种针对 COVID-19 后持续性嗅觉丧失患者的潜在非侵入性神经刺激策略。为了设计神经刺激策略,25 名因 COVID-19 感染而经历嗅觉丧失的受试者在接受嗅觉评估的同时记录他们的脑电图(EEG)信号。这些信号用于研究嗅觉过程中大脑区域的激活,并确定哪些区域适合神经刺激。之后,15 名受试者参与了基于在与嗅觉功能相关的选定大脑区域应用经颅直流电刺激(tDCS)的神经刺激策略的评估。结果表明,嗅觉评估得分较低的受试者比其他受试者获得了更大的改善。因此,tDCS 可能是 COVID-19 感染后尚未完全恢复嗅觉的人的一个有前途的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/4b42f1334914/sensors-23-05880-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/94de03ed97dc/sensors-23-05880-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/4dcfb0e2d4d1/sensors-23-05880-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/64f70358b55f/sensors-23-05880-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/1f45fd58c276/sensors-23-05880-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/39f9b7fafbbe/sensors-23-05880-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/4b42f1334914/sensors-23-05880-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/94de03ed97dc/sensors-23-05880-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/4dcfb0e2d4d1/sensors-23-05880-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/64f70358b55f/sensors-23-05880-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/1f45fd58c276/sensors-23-05880-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/39f9b7fafbbe/sensors-23-05880-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a32d/10346661/4b42f1334914/sensors-23-05880-g006.jpg

相似文献

1
Design and Evaluation of a Potential Non-Invasive Neurostimulation Strategy for Treating Persistent Anosmia in Post-COVID-19 Patients.设计和评估一种针对新冠病毒后持续性嗅觉丧失患者的潜在非侵入性神经刺激治疗策略。
Sensors (Basel). 2023 Jun 25;23(13):5880. doi: 10.3390/s23135880.
2
Injection of Platelet Rich Plasma in the Olfactory Cleft for COVID-19 Patients With Persistent Olfactory Dysfunction: Description of the Technique.富血小板血浆注射治疗 COVID-19 嗅觉障碍患者嗅觉障碍:技术描述。
Ear Nose Throat J. 2024 Jun;103(1_suppl):115S-119S. doi: 10.1177/01455613221124773. Epub 2022 Oct 11.
3
Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection.SARS-CoV-2 病毒感染后嗅觉障碍的治疗。
Ear Nose Throat J. 2024 Jun;103(1_suppl):48S-53S. doi: 10.1177/01455613231168487. Epub 2023 Mar 28.
4
Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell.COVID-19 相关持续性嗅觉丧失患者的经典嗅觉训练效果。
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):757-763. doi: 10.1007/s00405-022-07570-w. Epub 2022 Jul 29.
5
[Loss of smell, a preliminary indicator of COVID-19].[嗅觉丧失,新冠病毒病的一个初步指标]
Rev Med Inst Mex Seguro Soc. 2021 Feb 2;59(1):4-6. doi: 10.24875/RMIMSS.M21000046.
6
Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review.新型冠状病毒肺炎与嗅觉功能障碍的病理生理学关系:系统综述。
Braz J Otorhinolaryngol. 2022 Sep-Oct;88(5):794-802. doi: 10.1016/j.bjorl.2021.04.001. Epub 2021 Apr 25.
7
Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic.新冠嗅觉功能障碍的嗅觉训练:大流行神经认知后遗症下的有希望的缓解方法。
Clin Exp Pharmacol Physiol. 2022 Apr;49(4):462-473. doi: 10.1111/1440-1681.13626. Epub 2022 Feb 10.
8
Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-Analysis.目的:与主观方法相比,客观感觉测试方法显示 COVID-19 阳性患者的嗅觉丧失发生率更高:系统评价和荟萃分析。
Chem Senses. 2020 Dec 5;45(9):865-874. doi: 10.1093/chemse/bjaa064.
9
Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework.利用不良结局路径框架理解 COVID-19 导致短期嗅觉丧失的嗅神经上皮参与的机制。
Cells. 2022 Sep 27;11(19):3027. doi: 10.3390/cells11193027.
10
Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.持续性 COVID-19 嗅觉异常和嗅觉训练后嗅觉丧失:比较中枢和外周作用治疗药物的随机临床试验。
Eur Arch Otorhinolaryngol. 2024 Jul;281(7):3671-3678. doi: 10.1007/s00405-024-08548-6. Epub 2024 Mar 16.

引用本文的文献

1
Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review.新冠病毒感染嗅觉功能障碍的治疗:一项系统综述
Int Arch Otorhinolaryngol. 2024 May 25;28(4):e728-e743. doi: 10.1055/s-0044-1786046. eCollection 2024 Oct.

本文引用的文献

1
Management of Anosmia in COVID-19: A Comprehensive Review.新冠病毒感染所致嗅觉丧失的管理:一项综合综述
Cureus. 2022 Oct 18;14(10):e30425. doi: 10.7759/cureus.30425. eCollection 2022 Oct.
2
Recovery from Covid-19 smell loss: Two-years of follow up.新冠康复后嗅觉丧失的随访研究:两年观察。
Am J Otolaryngol. 2022 Sep-Oct;43(5):103607. doi: 10.1016/j.amjoto.2022.103607. Epub 2022 Aug 13.
3
Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves.
新冠病毒感染者嗅觉和味觉功能障碍的预后和持续性:使用参数治愈模型对恢复曲线进行荟萃分析。
BMJ. 2022 Jul 27;378:e069503. doi: 10.1136/bmj-2021-069503.
4
Assessment and Scientific Progresses in the Analysis of Olfactory Evoked Potentials.嗅觉诱发电位分析的评估与科学进展
Bioengineering (Basel). 2022 Jun 12;9(6):252. doi: 10.3390/bioengineering9060252.
5
Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled study.经颅直流电刺激(tDCS)对持续性新冠病毒感染嗅觉功能障碍的影响:一项双盲假对照研究。
J Neurol Neurosurg Psychiatry. 2023 Jan;94(1):87-88. doi: 10.1136/jnnp-2022-329162. Epub 2022 May 23.
6
Decreasing Incidence of Chemosensory Changes by COVID-19 Variant.新冠病毒变异导致化学感觉变化发生率降低。
Otolaryngol Head Neck Surg. 2023 Apr;168(4):704-706. doi: 10.1177/01945998221097656. Epub 2023 Feb 5.
7
Gas Recognition in E-Nose System: A Review.电子鼻系统中的气体识别:综述。
IEEE Trans Biomed Circuits Syst. 2022 Apr;16(2):169-184. doi: 10.1109/TBCAS.2022.3166530. Epub 2022 May 19.
8
SARS-CoV-2 is associated with changes in brain structure in UK Biobank.在英国生物银行中,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与大脑结构变化有关。
Nature. 2022 Apr;604(7907):697-707. doi: 10.1038/s41586-022-04569-5. Epub 2022 Mar 7.
9
The Olfactory System as Marker of Neurodegeneration in Aging, Neurological and Neuropsychiatric Disorders.嗅觉系统作为衰老、神经和神经精神疾病神经退行性变的标志物。
Int J Environ Res Public Health. 2021 Jun 29;18(13):6976. doi: 10.3390/ijerph18136976.
10
Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis.新冠病毒病确诊1年后嗅觉丧失患者的临床结局
JAMA Netw Open. 2021 Jun 1;4(6):e2115352. doi: 10.1001/jamanetworkopen.2021.15352.